Wikidata

(Q28302900)

English

Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumors

scientific article

In more languages

Statements

title
Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumors (English)
0 references
author name string
Geoffrey I Shapiro
series ordinal
1
0 references
Raoul Tibes
series ordinal
2
0 references
Michael S Gordon
series ordinal
3
0 references
Bryan Y Wong
series ordinal
4
0 references
Joseph Paul Eder
series ordinal
5
0 references
Mitesh J Borad
series ordinal
6
0 references
David S Mendelson
series ordinal
7
0 references
Nicholas J Vogelzang
series ordinal
8
0 references
Bruno R Bastos
series ordinal
9
0 references
Glen J Weiss
series ordinal
10
0 references
Cristian Fernandez
series ordinal
11
0 references
William Sutherland
series ordinal
12
0 references
Hitoshi Sato
series ordinal
13
0 references
William E Pierceall
series ordinal
14
0 references
David Weaver
series ordinal
15
0 references
Scott Slough
series ordinal
16
0 references
Ernesto Wasserman
series ordinal
17
0 references
Donald W Kufe
series ordinal
18
0 references
Daniel Von Hoff
series ordinal
19
0 references
Takumi Kawabe
series ordinal
20
0 references
Sunil Sharma
series ordinal
21
0 references
publication date
15 May 2011
0 references
volume
17
0 references
page(s)
3431-42
0 references
issue
10
0 references

Identifiers

PubMed ID
21220472
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q28302900&oldid=1585838757"